1[1]Fisher B,Redmond C,Poisson R,et al.Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with of without irradiation in the treatment or breast cancer.N Engl J Med,1989,320: 822-828.
2[2]Sarrazin D,Arriagada R,Contesso G,et al.Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer.Radiother Oncol,1989,14: 177-184.
3[3]Veronesi U,Banfi A,Salvadori B,et al.Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial.Eur J Cancer,1990,26:668-670.
4[4]van-Dongen JA,Bartelink H,Fentiman IS,et al.Randomized clinical trial to assess the value of breast-conserving therapy in stang I and Ⅱ breast cancer,EORTC 10801 trial.J Natl Cancer Inst Monogr,1992,11:5-18.
5[5]Blichert-Toft M,Rose C,Andersen JA,et al.Danish randomized trial comparing breast conservation therapy with mastectomy: six years of lifetable analysis.J Natl Cancer Inst Monogr,1992,11:19-25.
6[6]Lichter AS,Lippman ME,Danforth DN,et al.Mastectomy versus breast-conserving therapy in the treatment of stage I and Ⅱ carcinoma of the breast: a randomized trial at the National Cancer Institute.J Clin Oncol,1992,10:976-983.
7[7]Harbeck N,Kates RE,Look MP,et al.Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator(uPA) and plasmiogen activator inhibitor type 1(n=3424).Cancer Res,2002,62:4617-4622.
8[8]Keyomarsi K,Tucker SL,Buchholz TA,et al.Cyclin E and survival in patients with breast cancer.N Engl J Med,2002,347:1566-1575.
9[9]van-de-Vijver MJ,He YD,van't-Veer LJ,et al.A gene-expression signature as a predictor of survival in breast cancer.N Engl J Med,2002,347:1999-2009.
